Respiri Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Public

  • Employees
  • 2

Employees

  • Stock Symbol
  • VHL

Stock Symbol

  • Investments
  • 2

Respiri General Information

Description

Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.

Contact Information

Website
www.respiri.co
Formerly Known As
iSonea, KarmelSonix
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Level 9, 432 Street Kilda Road
  • Suite 1
  • Melbourne, Victoria 3004
  • Australia
Primary Industry
Other Healthcare Services
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • Level 9, 432 Street Kilda Road
  • Suite 1
  • Melbourne, Victoria 3004
  • Australia

Respiri Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Respiri Stock Performance

As of 17-Nov-2026, Respiri’s current market cap is $17.4M with 2.35B shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.4M 2.35B 1.09M

Respiri Financials Summary

As of 30-Sep-2026, Respiri has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 15,901 15,599 39,414 19,297
Revenue 2,904 2,002 299
EBITDA (6,339) (6,499) (4,587)
Net Income (7,188) (6,538) (4,672)
Total Assets 12,966 12,021 4,138
Total Debt 38 864
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Respiri Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Respiri‘s full profile, request access.

Request a free trial

Respiri Patents

Respiri Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023903329-A0 System and method for managing copd symptoms Inactive 19-Oct-2023
AU-2024362262-A1 System and method for managing copd symptoms Pending 19-Oct-2023
EP-4794582-A1 System and method for managing copd symptoms Pending 19-Oct-2023
WO-2025081220-A1 System and method for managing copd symptoms Inactive 19-Oct-2023
AU-2021903056-A0 Cough detection system Inactive 22-Sep-2021
To view Respiri’s complete patent history, request access »

Respiri Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Respiri Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Respiri‘s full profile, request access.

Request a free trial

Respiri Acquisitions (2)

Respiri’s most recent deal was a Merger/Acquisition with Orb Health for . The deal was made on 21-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Orb Health 21-Jan-2025 Merger/Acquisition Other Healthcare Technology Systems
Access Telehealth (Enterprise Systems) 07-Jun-2023 Merger/Acquisition Enterprise Systems (Healthcare)
To view Respiri’s complete acquisitions history, request access »

Respiri ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Respiri’s complete esg history, request access »

Respiri Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Access Telehealth (Enterprise Systems) Coral Springs, FL 2020
Orb Health Frisco, TX 2011

Respiri FAQs

  • When was Respiri founded?

    Respiri was founded in 1987.

  • Where is Respiri headquartered?

    Respiri is headquartered in Melbourne, Australia.

  • What is the size of Respiri?

    Respiri has 2 total employees.

  • What industry is Respiri in?

    Respiri’s primary industry is Other Healthcare Services.

  • Is Respiri a private or public company?

    Respiri is a Public company.

  • What is Respiri’s stock symbol?

    The ticker symbol for Respiri is VHL.

  • What is the current market cap of Respiri?

    The current market capitalization of Respiri is $17.4M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process